Maternal vaccination against COVID-19 and neonatal outcomes during Omicron: INTERCOVID-2022 study
- PMID: 38367758
- DOI: 10.1016/j.ajog.2024.02.008
Maternal vaccination against COVID-19 and neonatal outcomes during Omicron: INTERCOVID-2022 study
Abstract
Background: In early 2023, when Omicron was the variant of concern, we showed that vaccinating pregnant women decreased the risk for severe COVID-19-related complications and maternal morbidity and mortality.
Objective: This study aimed to analyze the impact of COVID-19 during pregnancy on newborns and the effects of maternal COVID-19 vaccination on neonatal outcomes when Omicron was the variant of concern.
Study design: INTERCOVID-2022 was a large, prospective, observational study, conducted in 40 hospitals across 18 countries, from November 27, 2021 (the day after the World Health Organization declared Omicron the variant of concern) to June 30, 2022, to assess the effect of COVID-19 in pregnancy on maternal and neonatal outcomes and to assess vaccine effectiveness. Women diagnosed with laboratory-confirmed COVID-19 during pregnancy were compared with 2 nondiagnosed, unmatched women recruited concomitantly and consecutively during pregnancy or at delivery. Mother-newborn dyads were followed until hospital discharge. The primary outcomes were a neonatal positive test for COVID-19, severe neonatal morbidity index, severe perinatal morbidity and mortality index, preterm birth, neonatal death, referral to neonatal intensive care unit, and diseases during the neonatal period. Vaccine effectiveness was estimated with adjustment for maternal risk profile.
Results: We enrolled 4707 neonates born to 1577 (33.5%) mothers diagnosed with COVID-19 and 3130 (66.5%) nondiagnosed mothers. Among the diagnosed mothers, 642 (40.7%) were not vaccinated, 147 (9.3%) were partially vaccinated, 551 (34.9%) were completely vaccinated, and 237 (15.0%) also had a booster vaccine. Neonates of booster-vaccinated mothers had less than half (relative risk, 0.46; 95% confidence interval, 0.23-0.91) the risk of being diagnosed with COVID-19 when compared with those of unvaccinated mothers; they also had the lowest rates of preterm birth, medically indicated preterm birth, respiratory distress syndrome, and number of days in the neonatal intensive care unit. Newborns of unvaccinated mothers had double the risk for neonatal death (relative risk, 2.06; 95% confidence interval, 1.06-4.00) when compared with those of nondiagnosed mothers. Vaccination was not associated with any congenital malformations. Although all vaccines provided protection against neonatal test positivity, newborns of booster-vaccinated mothers had the highest vaccine effectiveness (64%; 95% confidence interval, 10%-86%). Vaccine effectiveness was not as high for messenger RNA vaccines only. Vaccine effectiveness against moderate or severe neonatal outcomes was much lower, namely 13% in the booster-vaccinated group (all vaccines) and 25% and 28% in the completely and booster-vaccinated groups, respectively (messenger RNA vaccines only). Vaccines were fairly effective in protecting neonates when given to pregnant women ≤100 days (14 weeks) before birth; thereafter, the risk increased and was much higher after 200 days (29 weeks). Finally, none of the neonatal practices studied, including skin-to-skin contact and direct breastfeeding, increased the risk for infecting newborns.
Conclusion: When Omicron was the variant of concern, newborns of unvaccinated mothers had an increased risk for neonatal death. Neonates of vaccinated mothers had a decreased risk for preterm birth and adverse neonatal outcomes. Because the protective effect of COVID-19 vaccination decreases with time, to ensure that newborns are maximally protected against COVID-19, mothers should receive a vaccine or booster dose no more than 14 weeks before the expected date of delivery.
Keywords: COVID-19; COVID-19 vaccination; SARS-CoV-2; SARS-CoV-2 exposure; morbidity; mortality; multicenter study; neonatal health; neonatal intensive care admission; neonatal outcomes; neurologic outcomes; newborn; perinatal practices; pregnancy; preterm birth; respiratory support; respiratory symptoms; skin-to-skin.
Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Pregnancy outcomes and vaccine effectiveness during the period of omicron as the variant of concern, INTERCOVID-2022: a multinational, observational study.Lancet. 2023 Feb 11;401(10375):447-457. doi: 10.1016/S0140-6736(22)02467-9. Epub 2023 Jan 17. Lancet. 2023. PMID: 36669520 Free PMC article.
-
Effects of prenatal exposure to maternal COVID-19 and perinatal care on neonatal outcome: results from the INTERCOVID Multinational Cohort Study.Am J Obstet Gynecol. 2022 Sep;227(3):488.e1-488.e17. doi: 10.1016/j.ajog.2022.04.019. Epub 2022 Apr 19. Am J Obstet Gynecol. 2022. PMID: 35452653 Free PMC article.
-
Reductions in stillbirths and preterm birth in COVID-19-vaccinated women: a multicenter cohort study of vaccination uptake and perinatal outcomes.Am J Obstet Gynecol. 2023 May;228(5):585.e1-585.e16. doi: 10.1016/j.ajog.2022.10.040. Epub 2022 Nov 3. Am J Obstet Gynecol. 2023. PMID: 36336084 Free PMC article.
-
Outcome of coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy: a systematic review and meta-analysis.Am J Obstet Gynecol MFM. 2020 May;2(2):100107. doi: 10.1016/j.ajogmf.2020.100107. Epub 2020 Mar 25. Am J Obstet Gynecol MFM. 2020. PMID: 32292902 Free PMC article.
-
COVID-19 vaccination in pregnancy.Am J Obstet Gynecol. 2022 Aug;227(2):136-147. doi: 10.1016/j.ajog.2022.05.020. Epub 2022 May 11. Am J Obstet Gynecol. 2022. PMID: 35568189 Free PMC article. Review.
Cited by
-
Time to enhance COVID-19 vaccination in women of reproductive age.Lancet Reg Health Eur. 2024 Sep 10;45:101069. doi: 10.1016/j.lanepe.2024.101069. eCollection 2024 Oct. Lancet Reg Health Eur. 2024. PMID: 39308776 Free PMC article. No abstract available.
-
Timing of maternal vaccination against COVID-19 for effective protection of neonates: cohort study.Front Immunol. 2024 Jul 8;15:1359209. doi: 10.3389/fimmu.2024.1359209. eCollection 2024. Front Immunol. 2024. PMID: 39040104 Free PMC article.
-
COVID-19 vaccination and birth outcomes of 186,990 women vaccinated before pregnancy: an England-wide cohort study.Lancet Reg Health Eur. 2024 Aug 13;45:101025. doi: 10.1016/j.lanepe.2024.101025. eCollection 2024 Oct. Lancet Reg Health Eur. 2024. PMID: 39974773 Free PMC article.
-
Maternal COVID-19 infection and risk of respiratory distress syndrome among newborns: a systematic review and meta-analysis.BMC Infect Dis. 2024 Nov 19;24(1):1318. doi: 10.1186/s12879-024-10161-1. BMC Infect Dis. 2024. PMID: 39563236 Free PMC article.
-
Comparison of neonatal COVID-19 clinical features based on onset timing.Medicine (Baltimore). 2025 Jun 27;104(26):e43100. doi: 10.1097/MD.0000000000043100. Medicine (Baltimore). 2025. PMID: 40587662 Free PMC article.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous